BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29680229)

  • 1. ZAP-70 in chronic lymphocytic leukemia: A meta-analysis.
    Liu Y; Wang Y; Yang J; Bi Y; Wang H
    Clin Chim Acta; 2018 Aug; 483():82-88. PubMed ID: 29680229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zap-70 and CD38 as predictors of IgVH mutation in CLL.
    Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL
    Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor.
    Zanotti R; Ambrosetti A; Lestani M; Ghia P; Pattaro C; Remo A; Zanetti F; Stella S; Perbellini O; Prato G; Guida G; Caligaris-Cappio F; Menestrina F; Pizzolo G; Chilosi M
    Leukemia; 2007 Jan; 21(1):102-9. PubMed ID: 17082778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia.
    el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM
    Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia.
    D'Arena G; Tarnani M; Rumi C; Vaisitti T; Aydin S; De Filippi R; Perrone F; Pinto A; Chiusolo P; Deaglio S; Malavasi F; Laurenti L
    Am J Hematol; 2007 Sep; 82(9):787-91. PubMed ID: 17534928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia.
    Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status.
    Hüttmann A; Klein-Hitpass L; Thomale J; Deenen R; Carpinteiro A; Nückel H; Ebeling P; Führer A; Edelmann J; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2006 Oct; 20(10):1774-82. PubMed ID: 16932341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZAP-70 immunoreactivity is a prognostic marker of disease progression in chronic lymphocytic leukemia.
    Vener C; Gianelli U; Cortelezzi A; Fracchiolla NS; Somalvico F; Savi F; Pasquini MC; Bosari S; Deliliers GL
    Leuk Lymphoma; 2006 Feb; 47(2):245-51. PubMed ID: 16321853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
    Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
    N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry.
    Adams RL; Cheung C; Banh R; Saal R; Cross D; Gill D; Self M; Klein K; Mollee P
    Cytometry B Clin Cytom; 2014 Mar; 86(2):80-90. PubMed ID: 24127306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The study of different chromosomal aberrations, CD38 and ZAP-70 in chronic lymphocytic leukemia patients.
    Hassab AH; Elbordiny MM; Elghandour AH; Sorour AF; Swelem RS
    Egypt J Immunol; 2011; 18(2):77-93. PubMed ID: 23082473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
    Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zeta-associated protein 70 expression in chronic lymphocytic leukemia: Relevance in Indian context.
    Gupta R; Garg N; Singh A; Jain SL
    Indian J Pathol Microbiol; 2023; 66(2):291-294. PubMed ID: 37077070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MFI ratio estimation of ZAP-70 in B-CLL by flow cytometry can be improved by considering the isotype-matched antibody signal.
    Marquez ME; Deglesne PA; Suarez G; Romano E
    Int J Lab Hematol; 2011 Apr; 33(2):194-200. PubMed ID: 20942870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
    Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
    Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia.
    Orchard JA; Ibbotson RE; Davis Z; Wiestner A; Rosenwald A; Thomas PW; Hamblin TJ; Staudt LM; Oscier DG
    Lancet; 2004 Jan; 363(9403):105-11. PubMed ID: 14726163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZAP-70 staining in chronic lymphocytic leukemia.
    Villamor N
    Curr Protoc Cytom; 2005 May; Chapter 6():Unit 6.19. PubMed ID: 18770822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.